Navigation Links
Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
Date:12/15/2008

PARSIPPANY, N.J., Dec. 15 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that Under Pressure(TM), its national hypertension disease management program developed in accordance with JNC-7 guidelines, has received Disease Management Program Design Certification from the National Committee for Quality Assurance (NCQA), a private, not-for-profit organization dedicated to improving health care quality. NCQA certification signifies that the Under Pressure program has passed a rigorous review and successfully meets objective, evidence-based, high standards of health care quality.

"In addition to offering highly effective treatments in cardiovascular care, we are committed to ensuring that consumers have access to high quality, practical tools to help them take the best possible care of their hearts and bodies," said Kevin McDermott, Vice President, Managed Markets, Daiichi Sankyo, Inc. "The Daiichi Sankyo Managed Markets team is honored to represent this widely recognized symbol of quality from the NCQA for our Under Pressure program."

With a focus on improving quality of care, the Under Pressure initiative was launched in 2006 to foster partnerships between leading managed care organizations and the healthcare providers in charge of patient care. The patient is encouraged to be more actively involved in the management of their cardiovascular health by emphasizing the key elements necessary to live with hypertension including diet, exercise and medication. Health plans drive the initiative by inviting appropriate plan members to participate in the campaign. Once patients opt-in, they receive regular educational mailings including an innovative DVD, and are directed to a program Web site featuring articles, which reinforce the educational mailings. Earlier this year, Daiichi Sankyo announced a culturally competent version of the Under Pressure initiative designed for African-Americans wit
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
2. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
3. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
4. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
5. Travel Nurse Across America Awarded Certification From The Joint Commission
6. Dr. Ben Berkhout awarded Retrovirology Prize for contribution to HIV research
7. Perot Systems Awarded Contract Extension By Daughters of Charity
8. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
9. Jefferson researcher awarded NIH grant
10. Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan
11. Biocept Awarded Accreditation by the College of American Pathologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part ... the latest and coolest applications on the market for ... NewsWatch and technology expert, conducted the app review and ... runner game with knights, nature, and peasants. , ... according to Eurogamer. The popularity of these games grew ...
(Date:3/28/2015)... New York, New York (PRWEB) March 28, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. ... multidistrict litigation underway in U.S. District Court, Southern ... Jeffrey S. Grand, is serving on the Plaintiffs’ ... March 24th, the Court has granted certain defendants ...
(Date:3/28/2015)... Orlando, FL (PRWEB) March 28, 2015 ... pre-existing conditions coverage is made available to all visitors ... States, effective immediately. All members are encouraged to purchase ... finalized to avoid lack of proper coverage for pre-existing ... suffer from one or two medical conditions with serious ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... correlate with a history of shoulder and elbow injuries, according ... for Sports Medicine’s ( AOSSM ) Specialty Day. , “Our ... associated with a 20% increase in likelihood of a history ... is associated with a 12% increase likelihood of a history ...
(Date:3/28/2015)... Delaying rotator cuff surgery on patients with ... presented today at the American Orthopaedic Society for Sports ... compared results for 170 patients who received rotator cuff ... capsule release procedure to relieve stiffness at the time ... from St. George Hospital in Sydney, Australia. “Both groups ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2
... a combined treatment of hormonal therapy and the drug, Herceptin ... breast cancer by over half, according to a recent report. ... the treatment to be made available for even more women ... addition of Herceptin to hormonal therapy kept a control over ...
... The 'baby-boom' of the 1960s and 1970s is largely ... services for people with an intellectual disability // ... reveals that the demand for intellectual disability services is ... of the best levels of service provided and huge ...
... was made at a major conference on brain tumours in ... , ,According to the Irish Cancer Society, in spite of ... rate of success and any damge to the delicate tissue ... there were 316 new cases of primary brain tumour diagnosed ...
... novel method of protection against bird flu has been studied and ... Rochester. // This involves a way of getting around the problem ... months to develop a vaccine. Also, two doses of vaccine would ... study is a" prime and boost" method of vaccination. An initial ...
... would be safer to carry out a stomach-stapling surgery by ... // ,Around 1 million bariatric surgeries ... recommended for weight loss and it involves stapling of the ... ,“Doing the surgery without incisions will make it ...
... mysterious viral outbreak has forced a Canadian University to shut ... This is thought to be a Norwalk-type virus that has ... New Brunswick and in the surrounding university town of Sackville. ... officials to investigate the outbreak. ,"They spent three hours on ...
Cached Medicine News:Health News:Awake Surgery to treat Brain tumours 2Health News:NOTE surgery – to combat obesit 2Health News:Mystery outbreak causes Canadian University to shut down 2
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
(Date:3/26/2015)... WOODBRIDGE, ON , March 26, 2015 /PRNewswire/ - Pivotal ... specialty pharmaceutical company with a focus on Omega-3 therapies ... March 25, 2015 it issued 763,752 common shares of ... payment of interest for the period of December 5 ... on its outstanding Convertible Notes that is due on ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... 16, 2011 DecisionView Inc., a leading provider ... for life sciences companies, today announced that a ... Roche have agreed to participate in the creation ... based on real-world clinical performance data. Each of ...
... N.J., June 16, 2011 Ferring Pharmaceuticals Inc. proudly ... Houston in an effort to help increase awareness about ... of healthy aging. The NSG is ... and is organized by the National Senior Games Association, ...
Cached Medicine Technology:DecisionView to Create Clinical Trial Enrollment Benchmarks 2DecisionView to Create Clinical Trial Enrollment Benchmarks 3Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 2Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 3Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 4
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
Medicine Products: